Patients With ALS and Other Motor Disorders Will be Treated With Mesenchymal Cell Exosome Solution

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 14, 2024

Primary Completion Date

March 14, 2025

Study Completion Date

March 14, 2025

Conditions

Motor Disorders

Interventions

BIOLOGICAL

AlloEx exosomes

This is an intranasal treatment of exosomes derived from mesenchymal stem cells.

Trial Locations (1)

Medical Surgical Associates Center, St John's

All Listed Sponsors

lead

The Foundation for Orthopaedics and Regenerative Medicine

OTHER

NCT07105371 - Patients With ALS and Other Motor Disorders Will be Treated With Mesenchymal Cell Exosome Solution | Biotech Hunter | Biotech Hunter